← Evidence map

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026

Letter to the editor response for: "Schneider LS, Kennedy RE, Cutter G. Caution in interpreting disease-modification claims with lecanemab: selective reporting and causal inference. Alzheimer's & Dementia. 2026".

Christopher H van DyckPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Letter to the editor response for: "Schneider LS, Kennedy RE, Cutter G. Caution in interpreting disease-modification claims with lecanemab: selective reporting and causal inference. Alzheimer's & Dementia. 2026". | OpenQuestion